Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for KRAS-mutant cancers
1Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, East China Normal University, Shanghai 200241, China
2Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an 710061, China
3Shanghai Frontiers Science Center for Drug Target Identification and Delivery, State Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China
4Chongqing Institute of East China Normal University, Chongqing 401120, China
收起